Logo image of XCUR

EXICURE INC (XCUR) Stock Price, Quote, News and Overview

NASDAQ:XCUR - Nasdaq - US30205M3097 - Common Stock - Currency: USD

9.9  +1.46 (+17.3%)

XCUR Quote, Performance and Key Statistics

EXICURE INC

NASDAQ:XCUR (4/21/2025, 12:00:44 PM)

9.9

+1.46 (+17.3%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High36
52 Week Low1.44
Market Cap62.57M
Shares6.32M
Float1.54M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)06-16 2025-06-16
IPO05-09 2018-05-09


XCUR short term performance overview.The bars show the price performance of XCUR in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 50 100 150 200

XCUR long term performance overview.The bars show the price performance of XCUR in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 50 -50 100 150 200

The current stock price of XCUR is 9.9 USD. In the past month the price decreased by -37.76%. In the past year, price increased by 200.89%.

EXICURE INC / XCUR Daily stock chart

XCUR Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 16.85 301.62B
AMGN AMGEN INC 13.83 147.42B
GILD GILEAD SCIENCES INC 22.55 129.60B
VRTX VERTEX PHARMACEUTICALS INC 1663.62 124.03B
REGN REGENERON PHARMACEUTICALS 12.3 61.38B
ARGX ARGENX SE - ADR 323.94 36.79B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 30.31B
ONC BEIGENE LTD-ADR N/A 24.89B
BNTX BIONTECH SE-ADR N/A 24.66B
NTRA NATERA INC N/A 19.36B
SMMT SUMMIT THERAPEUTICS INC N/A 18.41B
BIIB BIOGEN INC 7.07 17.04B

About XCUR

Company Profile

XCUR logo image Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. The company is headquartered in Chicago, Illinois and currently employs 6 full-time employees. The company went IPO on 2018-05-09. The Company, through GPCR Therapeutics USA Inc. (GPCR USA), is focused on developing and commercializing an intellectual property and patents related to G-Protein Coupled Receptors. GPCR USA is conducting a Phase II clinical trial for a blood cancer treatment involving GPC-100 (Burixafor). The firm is also exploring strategic alternatives to maximize stockholder value.

Company Info

EXICURE INC

2430 N. Halsted St.

Chicago ILLINOIS 60614 US

CEO: David A. Giljohann

Employees: 5

Company Website: https://www.exicuretx.com/

Investor Relations: http://investors.exicuretx.com/overview/default.aspx

Phone: 18476731700

EXICURE INC / XCUR FAQ

What is the stock price of EXICURE INC today?

The current stock price of XCUR is 9.9 USD. The price increased by 17.3% in the last trading session.


What is the ticker symbol for EXICURE INC stock?

The exchange symbol of EXICURE INC is XCUR and it is listed on the Nasdaq exchange.


On which exchange is XCUR stock listed?

XCUR stock is listed on the Nasdaq exchange.


What is EXICURE INC worth?

EXICURE INC (XCUR) has a market capitalization of 62.57M USD. This makes XCUR a Micro Cap stock.


How many employees does EXICURE INC have?

EXICURE INC (XCUR) currently has 5 employees.


What are the support and resistance levels for EXICURE INC (XCUR) stock?

EXICURE INC (XCUR) has a support level at 8.43 and a resistance level at 14.28. Check the full technical report for a detailed analysis of XCUR support and resistance levels.


Should I buy EXICURE INC (XCUR) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does EXICURE INC (XCUR) stock pay dividends?

XCUR does not pay a dividend.


When does EXICURE INC (XCUR) report earnings?

EXICURE INC (XCUR) will report earnings on 2025-06-16.


What is the Price/Earnings (PE) ratio of EXICURE INC (XCUR)?

EXICURE INC (XCUR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-4.15).


What is the Short Interest ratio of EXICURE INC (XCUR) stock?

The outstanding short interest for EXICURE INC (XCUR) is 3.25% of its float. Check the ownership tab for more information on the XCUR short interest.


XCUR Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to XCUR. When comparing the yearly performance of all stocks, XCUR is one of the better performing stocks in the market, outperforming 98.42% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

XCUR Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to XCUR. XCUR scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

XCUR Financial Highlights

Over the last trailing twelve months XCUR reported a non-GAAP Earnings per Share(EPS) of -4.15. The EPS decreased by -45.96% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -64.43%
ROE -143.25%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-220.7%
Sales Q2Q%N/A
EPS 1Y (TTM)-45.96%
Revenue 1Y (TTM)N/A

XCUR Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 43% to XCUR. The Buy consensus is the average rating of analysts ratings from 6 analysts.


Ownership
Inst Owners11.83%
Ins Owners16.64%
Short Float %3.25%
Short Ratio0.36
Analysts
Analysts43.33
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A